Verition Fund Management
CASC

Verition Fund Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Verition Fund Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,660
Closed -$57K – 1391
2017
Q1 		$57K Buy
+13,660
New +$57K 0.01% 1060